Anne Tremaine is a Dermatology physician. OpenAlex indexes 18 publications with 388 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8625 Collier Blvd
Naples, FL 341143550
Telephone
239-732-0044Registry record last updated 10 Jan 2017.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Organogenesis Inc.Program year20253 payments
- ABBVIE INC.Program year20256 payments
- Janssen Biotech, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
41.8%Tetracycline-class Drug12.4%Doxycycline Hyclate93%Doxycycline Monohydrate7%Part D<11 patientsAzole Antifungal11.1%Ketoconazole100%Part D≥83 patients+ 4 more classes in this area
Dermatology
25.7%Corticosteroid20.4%Triamcinolone Acetonide58%Triamcinolone acetonide29%Methylprednisolone7%Fluocinolone Acetonide6%Part D + Part B≥136 patientsPolyene Antifungal2.3%Nystatin100%Part D≥17 patients+ 2 more classes in this area
Sensory organs
12.3%Corticosteroid12.3%Betamethasone Dipropionate48%Hydrocortisone27%Clobetasol Propionate25%Part D≥57 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- FDA MAUDE data on complications with lasers, light sources, and energy‐based devices
Lasers in Surgery and Medicine
2015 - A scarring reaction to the treatment of basal cell carcinoma with ingenol mebutate.
PubMed
2015 - Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod
Journal of the American Academy of Dermatology
2012
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”